Secondary atrial septal defect in eldery patients: practical reviw

Gurev V.V., Zverev D.A., Strelkov D.A., Kucherenko V.S.

Secondary atrial septal defect (ASD) is one of the most common congenital heart defects (CHD), a clinical picture which is mainly caused by the shunting of blood between the systemic and pulmonary circulation. If the defect is not corrected, the existing volume overloading of the heart over time leads to various cardiac complications and an early, compared with healthy people, mortality. Transcatheter and surgical methods for the correction of ASD show similar results, but, nevertheless, transcatheter closure of the defect is more preferable, especially in adults and elderly patients. Correction of the defect is indicated in all patients with hemodynamically significant shunt at the level of atrials, regardless of age and symptoms except for patients with concomitant severe or irreversible pulmonary hypertension. Clinical symptoms and survival rate are in inverse proportion to the age of the patient, the degree of pulmonary hypertension and time correction of the defect. The article proposed the algorithm for selection and management of adult patients with secondary ASD.

1. Zin’kovskii MF. Vrozhdennye poroki serdtsa. Ed by A.F. Vozianov. Kiev; 2010. pp. 226–237. (In Russ).

2. Zorin AB, Schukin VI, Shevchenko YuL, Palamarchuk TV. Autopericardium plasty of the cardiac septa. Grudn Khir. 1978;(2):8–31. (In Russ).

3. Chastnaya khirurgiya. Uchebnik dlya meditsinskikh vuzov. Ed by Yu.L. Shevchenko. Vol. 1. St. Petersburg: Spetsial’naya literatura; 1998. 517 p. (In Russ).

4. Abaci A, Unlu S, Alsancak Y, et al. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta–analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013;82(7):1123–1138. doi: 10.1002/ccd.24875

5. Ayres NA, Miller-Hance W, Fyfe DA, et al. Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2005;18(1):91–98. doi: 10.1016/j.echo.2004.11.004.

6. Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999;68(1):75–78. doi: 10.1016/S0003-4975(99)00478-6.

7. Billinger M, Zbinden R, Mordasini R, et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart. 2011;97(23):1932–1937. doi: 10.1136/heartjnl-2011-300436.

8. Buiatti A, Hessling G, Semmler V, Ammar S. Remote magnetic navigation for persistent atrial fibrillation ablation via a retrograde aortic access: an approach for patients after atrial septal defect device closure. Clin Res Cardiol. 2014;103(12): 1028–1030. doi: 10.1007/s00392–014–0747–6.

9. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970;32(6): 820–826. doi: 10.1136/hrt.32.6.820.

10. Campbell M, Neill C, Suzman S. The prognosis of atrial septal defect. Br Med J. 1957;1(5032):1375–1383. doi: 10.1136/bmj.1.5032.1375.

11. Cordell HJ, Bentham J, Topf A, et al. Genome–wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet. 2013;45(7):822–824. doi: 10.1038/ng.2637.

12. Dell’avvocata F, Rigatelli G, Cardaioli P, Giordan M. Home-made fenestrated amplatzer occluder for atrial septal defect and pulmonary arterial hypertension. J Geriatr Cardiol. 2011;8(2):127–129. doi: 10.3724/SP.J.1263.2011.00127.

13. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115(8):1039–1050. doi: 10.1161/CIRCULATIONAHA.105.592386.

14. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915–2957. doi: 10.1093/eurheartj/ehq249.

15. Engelfriet P, Meijboom F, Boersma E, et al. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. Int J Cardiol. 2008;126(3):379–385. doi: 10.1016/j.ijcard.2007.04.044.

16. Engelfriet PM, Duffels MG, Möller T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart. 2007;93(6):682–687. doi: 10.1136/hrt.2006.098848.

17. Fredriksen PM, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87(3):310–314. doi: 10.1016/S0002-9149(00)01364-3.

18. Gabriels C, De Meester P, Pasquet A, et al. A different view on predictors of pulmonary hypertension in secundum atrial septal defect. Int J Cardiol. 2014;176(3):833–840. doi: 10.1016/j.ijcard.2014.08.009.

19. Gatzoulis MA, Freeman MA, Siu SC, et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–846. doi: 10.1056/NEJM199903183401103.

20. Giardini A, Donti A, Formigari R, et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol. 2004;43(10):1886–1891. doi: 10.1016/j.jacc.2003.10.067.

21. Giardini A, Donti A, Sciarra F, et al. Long-term incidence of atrial fibrillation and flutter after transcatheter atrial septal defect closure in adults. Int J Cardiol. 2009; 134(1):47–51. doi: 10.1016/j.ijcard.2008.02.003.

22. Grothues F, Moon JC, Bellenger NG, et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004;147(2):218–223. doi: 10.1016/j.ahj.2003.10.005.

23. Heller J, Hagège AA, Besse B, et al. “Crochetage”(notch) on R wave in inferior limb leads: a new independent electrocardiographic sign of atrial septal defect. J Am Coll Cardiol. 1996;27(4):877–882. doi: 10.1016/0735-1097(95)00554-4.

24. Hopkins RA, Bert AA, Buchholz B, et al. Surgical patch closure of atrial septal defects. Ann Thorac Surg. 2004;77(6):2144–2149. doi: 10.1016/j.athoracsur. 2003.10.105.

25. Kobayashi J, Yamamoto F, Nakano K, et al. Maze procedure for atrial fibrillation associated with atrial septal defect. Circulation. 1998;98(19 Suppl):II399–402.

26. Konstantinides S, Geibel A, Olschewski M, et al A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med. 1995;333(8): 469–473. doi: 10.1056/NEJM199508243330801.

27. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43(2):302–309. doi: 10.1016/j.jacc.2003.10.030.

28. Lembcke A, Dohmen PM, Dewey M, et al. Multislice computed tomography for preoperative evaluation of right ventricular volumes and function: comparison with magnetic resonance imaging. Ann Thorac Surg. 2005;79(4):1344–1351. doi: 10.1016/j.athoracsur.2004.09.030.

29. Lok SI, Winkens B, Dimopoulos K, et al. Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect. Int J Cardiol. 2010;142(1):44–49. doi: 10.1016/j.ijcard.2008.12.085.

30. Luks AM, Stout K, Swenson ER. Evaluating the safety of high-altitude travel in patients with adult congenital heart disease. Congenit Heart Dis. 2010;5(3):220–232. doi: 10.1111/j.1747-0803.2010.00415.x.

31. Majunke N, Bialkowski J, Wilson N, et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol. 2009;103(4):550–554. doi: 10.1016/j.amjcard.2008.10.018.

32. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007; 115(2):163–172. doi: 10.1161/CIRCULATIONAHA.106.627224.

33. Mohan RA, van Engelen K, Stefanovic S, et al. A mutation in the Kozak sequence of GATA4 hampers translation in a family with atrial septal defects. Am J Med Genet A. 2014;164A(11):2732–2738. doi: 10.1002/ajmg.a.36703.

34. Mulder BJ. Not too old to be closed… Neth Heart J. 2010;18(11):520–521. doi: 10.1007/s12471-010-0826-x.

35. Mullen MJ, Hildick-Smith D, De Giovanni JV, et al. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial–level shunts. Circulation. 2006;114(18):1962–1967.doi: 10.1161/CIRCULATIONAHA.106.664672.

36. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med. 1990;323(24):1645–1650. doi: 10.1056/NEJM199012133232401.

37. Nyboe C, Fenger-Grøn M, Nielsen-Kudsk JE, Hjortdal V. Closure of secundum atrial septal defects in the adult and elderly patients. Eur J Cardiothorac Surg. 2013;43(4):752–757. doi: 10.1093/ejcts/ezs405.

38. Pérez Matos AJ, Planken RN, Bouma BJ, et al. Unroofed coronary sinus newly diagnosed in adult patients after corrected congenital heart disease. Neth Heart J. 2014;22(5):240–245. doi: 10.1007/s12471-014-0533-0.

39. Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):3015–3038. doi: 10.1161/CIRCULATIONAHA. 106.674812.

40. Podnar T, Martanovic P, Gavora P, Masura J. Morphological variations of secundum type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv. 2001;53(3):386–391. doi: 10.1002/ccd.1187.

41. Rao PS, Palacios IF, Bach RG, et al. Platypnea–orthodeoxia: Management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv. 2001;54(1):77–82. doi: 10.1002/ccd.1243.

42. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age: a prospective follow-up study of 21–33 years. Eur Heart J. 2003;24(2):190–197. doi: 10.1016/S0195-668X(02)00383-4.

43. Rosas M, Zabal C, Garcia-Montes J, et al. Transcatheter versus surgical closure of secundum atrial septal defect in adults: impact of age at intervention. A concurrent matched comparative study. Congenit Heart Dis. 2007;2(3):148–155. doi: 10.1111/j.1747-0803.2007.00091.x.

44. Saminek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol. 1992;13(3):152–158. doi: 10.1007/BF00793947.

45. Santangeli P, Di Biase L, Burkhardt JD, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8(11):1669–1675. doi: 10.1016/j.hrthm.2011.06.023.

46. John Sutton MG, Tajik AJ, McGoon DC. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up. Circulation. 1981;64(2):402–409. doi: 10.1161/01.cir.64.2.402.

47. van Riel AC, Schuuring MJ, van Hessen ID, et al. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. 2014;174(2):299–305. doi: 10.1016/j.ijcard.2014.04.072.

48. Wessels MW, Willems PJ. Genetic factors in non–syndromic congenital heart malformations. Clin Genet. 2010;78(2):103–123. doi: 10.1111/j.1399-0004.2010.01435.x.

49. Yap SC, Drenthen W, Meijboom FJ, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG. 2009;116(12):1593–1601. doi: 10.1111/j.1471-0528.2009.02301.x.